Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Drug & Device News
Trade Secrets vs. the Public's Right to Know
As part of its efforts to combat rampant drug abuse, the City of Chicago is suing several opioid-drug manufacturers, claiming that they have engaged in “a scheme to misinform the health care community and consumers about the risks, benefits and superiority of the opium-like painkillers” they manufacture. The City agreed to redaction of part of the complaint and some of the pre-suit investigative materials, at the drug manufacturers' request, the manufacturers asserting that these things included confidential company information. But three news outlets ' The Los Angeles Times, USA Today and The Chicago Tribune ' moved in mid-July to intervene in the lawsuit to unseal the redacted materials. They claim that their First Amendment and common law rights to access to judicial proceedings are being limited by the redactions, and that the public has a right to know what is happening in the case. Named in the lawsuit are pharmaceuticals companies Actavis PLC, Cephalon Inc., Endo Health Solutions Inc., Janssen Pharmaceuticals Inc., Johnson & Johnson, the Purdue Frederick Company Inc., Purdue Pharma Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries, Ltd.
'
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Yachts, Jets, Horses & Hooch: Specialized Commercial Leasing Models
Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
Hyperlinked Documents: The Latest e-Discovery Challenge
As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.
Identifying Your Practice's Differentiator
How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
Risks and Ad Fraud Protection In Digital Advertising
The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
Turning Business Development Plans Into Reality
This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.